BSX Q3 2025 Earnings Transcript

Motley Fool Transcribing, The Motley Fool

Wed, April 22, 2026 astatine 10:07 AM CDT 46 min read

Image source: The Motley Fool.

Oct. 22, 2025, 8 a.m. ET

• Chairman and Chief Executive Officer — Michael F. Mahoney

• Executive Vice President and Chief Financial Officer — Jonathan D. Monson

• Chief Medical Officer — Dr. Ken Stein

• Vice President, Investor Relations — Lauren Tengler

Lauren Tengler: Thank you, Drew, and acknowledgment to everyone for joining us. With maine contiguous are Mike Mahoney, Chairman and Chief Executive Officer; Jon Monson, Executive Vice President and Chief Financial Officer. During the Q&A session, Mike and Jon volition beryllium joined by our Chief Medical Officer, Dr. Ken Stein. We issued a property merchandise earlier this greeting announcing our Q3 results, which included reconciliations of the non-GAAP measures. The merchandise arsenic good arsenic reconciliations of the non-GAAP measures utilized successful today's telephone tin beryllium recovered connected the Investor Relations conception of our website.

Please enactment that connected the call, operational gross excludes the interaction of overseas currency fluctuations, and integrated gross further excludes definite acquisitions and divestitures for which determination are little than a afloat play of comparable nett sales. Guidance excludes the antecedently announced statement to get Nalu Medical, which is expected to adjacent successful the archetypal fractional of 2026, taxable to customary closing conditions. For much information, delight notation to the Q3 fiscal and operating highlights platform which whitethorn beryllium recovered connected the Investor Relations conception of our website. On this call, each references to income and gross are organic, and comparative maturation is compared to the aforesaid 4th of the anterior year, unless different specified.

This telephone contains forward-looking statements regarding, among different things, our fiscal performance, concern plans and merchandise show and development. These statements are based connected our existent beliefs utilizing accusation disposable to america arsenic of today's day and are not intended to beryllium guarantees of aboriginal events oregon performance. If our underlying assumptions crook retired to beryllium incorrect oregon definite risks oregon uncertainties materialize, existent results could alteration materially from those projected connected -- by the forward-looking statements. Factors that whitethorn origin specified differences are discussed successful our periodic reports and different filings with the SEC, including the Risk Factors conception of our astir caller yearly study connected Form 10-K.

Boston Scientific disclaims immoderate volition oregon work to update these forward-looking statements, but arsenic required by law. At this point, I'll crook it implicit to Mike.